Immunotherapy drugs that enhance the body’s immune system are making significant strides in treating early-stage cancer. This development has the potential to expand their use and transform care for hard-to-treat diseases like gastric and colon cancer.
Several immunotherapy treatments, including Opdivo from Bristol Myers Squibb Co., Imfinzi from AstraZeneca PLC, and Tecentriq from Roche Holding AG, have seen impressive results in increasing survival times for advanced cancers.
Source: https://www.bloomberg.com/news/articles/2025-06-01/early-stage-cancer-can-be-treated-by-immunotherapy-drugs-studies-show